Middle East & Africa Rare Hemophilia Factors Market Size & Outlook
Related Markets
MEA rare hemophilia factors market highlights
- The MEA rare hemophilia factors market generated a revenue of USD 11.0 million in 2024.
- The market is expected to grow at a CAGR of 5.3% from 2025 to 2030.
- In terms of segment, factor vii deficiency was the largest revenue generating factor deficiency in 2024.
- Factor XIII Deficiency is the most lucrative factor deficiency segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 11.0 million |
| Market revenue in 2030 | USD 15.0 million |
| Growth rate | 5.3% (CAGR from 2025 to 2030) |
| Largest segment | Factor vii deficiency |
| Fastest growing segment | Factor XIII Deficiency |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Factor VII Deficiency, Factor XI Deficiency (Hemophilia C), Factor XIII Deficiency, Other Rare Factor Deficiencies |
| Key market players worldwide | Novo Nordisk A/S ADR, Biogen Inc, Bayer AG, Pfizer Inc, Takeda Pharmaceutical Co Ltd, Baxalta, CSL Ltd, Bio Products Laboratory |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.3% of the global rare hemophilia factors market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 132.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Hemophilia Factors Market Scope
Rare Hemophilia Factors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Baxalta | View profile | 10001+ | Illinois City, Illinois, United States, North America | http://www.baxalta.com |
| Bio Products Laboratory | View profile | 501-1000 | Kingdom City, Missouri, United States, North America | http://www.bplgroup.com/ |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Middle East & Africa rare hemophilia factors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare hemophilia factors market will help companies and investors design strategic landscapes.
Factor vii deficiency was the largest segment with a revenue share of 37.27% in 2024. Horizon Databook has segmented the Middle East & Africa rare hemophilia factors market based on factor vii deficiency, factor xi deficiency (hemophilia c), factor xiii deficiency, other rare factor deficiencies covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa rare hemophilia factors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa rare hemophilia factors market databook
-
Our clientele includes a mix of rare hemophilia factors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa rare hemophilia factors market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa rare hemophilia factors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA rare hemophilia factors market size, by country, 2018-2030 (US$M)
Middle East & Africa Rare Hemophilia Factors Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
